| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $90.4M | +9.3% |
| Cost of Revenue | $8.9M | -5.1% |
| Gross Profit | $81.5M | +11.1% |
| R&D Expense | $57.1M | +25.3% |
| SG&A Expense | $121.2M | +29.9% |
| Operating Income | -$96.8M | -47.7% |
| Pre-tax Income | -$124.0M | -26.2% |
| Income Tax | $2.8M | -27.8% |
| Net Income | -$126.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $172.0M | +81.0% |
| Short-term Investments | $110.7M | +97.1% |
| Accounts Receivable | $20.3M | +31.5% |
| Inventory | $9.2M | +62.6% |
| Current Assets | $276.1M | +63.2% |
| Total Assets | $285.7M | +60.2% |
| Current Liabilities | $45.9M | +47.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$96.8M | -26.7% |
| Capital Expenditures | $295K | +52.1% |
| Investing Cash Flow | -$20.6M | -2063.0% |
| Financing Cash Flow | $194.6M | +66.4% |
| Free Cash Flow | -$97.1M | -26.8% |
| -24.1% |
| EPS (Basic) | -$2.96 | +16.6% |
| Long-term Debt |
| $121.7M |
| +23.5% |
| Total Liabilities | $294.5M | +20.9% |
| Stockholders' Equity | -$8.8M | +86.5% |